CARMEN DAVIS: Open Payments
NPI 1598973083 · SOMERSET, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,677 in 118 payments from 16 companies in 2025. Trend: 2023 $1,957 · 2024 $2,389 · 2025 $2,677
Food & beverage: $2,526Education: $151
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 10 | $315 |
| Janssen Biotech, Inc. | 7 | $292 |
| LEO Pharma Inc. | 13 | $245 |
| Galderma Laboratories, L.P. | 12 | $240 |
| ABBVIE INC. | 13 | $237 |
| E.R. Squibb & Sons, L.L.C. | 8 | $201 |
| Lilly USA, LLC | 7 | $200 |
| PFIZER INC. | 11 | $194 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $188 |
| Novartis Pharmaceuticals Corporation | 8 | $182 |
Products named: OPZELURA, TREMFYA, TALTZ, NEMLUVIO, CIBINQO, SKYRIZI, ADBRY, COSENTYX.
Industry payments across NJ — which companies pay providers there.
